Nano-Check Influenza+COVID-19 Dual Test

FDA 510(k) K243561 · Nano-Ditech Corporation

Substantially Equivalent

510(k) numberK243561

Submission

Device name
Nano-Check Influenza+COVID-19 Dual Test
Applicant
Nano-Ditech Corporation
Cranbury, NJ, US
Received
November 18, 2024
Decision date
June 17, 2025
Decision
Substantially Equivalent (SESE)
Type
Dual Track 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
SCA – Multi-Analyte Respiratory Virus Antigen Detection Test
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3987
Specialty
Microbiology

A multi-analyte respiratory virus antigen detection test is an in vitro diagnostic device intended for the detection and/or differentiation of respiratory viruses directly from respiratory clinical specimens. The device is intended to be performed at the site of sample collection, does not involve sample storage and/or transport.

Other 510(k)s with product code SCA

510(k)DeviceApplicantDecision
K261212Flowflex Plus RSV + Flu A/B + COVID Rapid TestSCA · Dual Track ACON Laboratories, Inc.07/10/2026SE
K251092iHealth Flu A&B/COVID-19 Rapid Test; iHealth Flu A&B/COVID-19 Rapid Test ProSCA · Traditional Ihealth Labs, Inc.12/12/2025SE
K251085iHealth Flu A&B/COVID-19/RSV Rapid Test; iHealth Flu A&B/COVID-19/RSV Rapid Test ProSCA · Traditional Ihealth Labs, Inc.12/12/2025SE
K251538Status™ COVID-19/Flu A&BSCA · Dual Track Princeton BioMeditech Corp.11/14/2025SE
K251749Flowflex Plus RSV + Flu A/B + COVID Home TestSCA · Traditional ACON Laboratories, Inc.10/22/2025SE
K251604CareSuperb COVID-19/Flu A&B Antigen Combo Home TestSCA · Traditional Access Bio, Inc.08/22/2025SE
K251563WELLlife Flu A&B Home Test; WELLlife Influenza A&B TestSCA · Traditional Wondfo USA Co, Ltd.08/20/2025SE
K250377Flowflex Plus COVID-19 + Flu A/B Home TestSCA · Traditional ACON Laboratories, Inc.05/10/2025SE
K243256WELLlife™ COVID-19 / Influenza A&B Home Test; WELLlife™ COVID-19 / Influenza A&B…SCA · Traditional Wondfo USA Co, Ltd.01/16/2025SE
K243262QuickFinder COVID-19/Flu Antigen Self Test / QuickFinder COVID-19/Flu Antigen Pro TestSCA · Traditional Osang, LLC01/13/2025SE

More from Osang, LLC

510(k)DeviceDecision
K252283Nano-Check Influenza A+B TestPSZ · Dual Track 01/15/2026SE
K240280Nano-Check™ RSV TestGQG · Dual Track 07/30/2024SE
K231187Nano-Check™ COVID-19 Antigen TestQVF · Traditional 01/23/2024SE
K102441Nano-Check Ami 2 in 1 Cardiac Marker, CTNL and MyoglobinMMI · Special 10/20/2010SE
K102131Nano-Check Ami Ctni Cardiac Marker TestMMI · Special 10/20/2010SE
K050975Nano-Check Ami 3 in 1 Cardiac Disease Test for Cardiac Troponin I, Creatine Kinase MB…MMI · Traditional 03/02/2006SE
K050594Nano-Check Dat 5 Multi Drug Screening Test for Cannabinoids, Opiates, Cocaine…LDJ · Traditional 05/15/2005SE

Questions and answers

When was Nano-Check Influenza+COVID-19 Dual Test cleared by the FDA?

Nano-Check Influenza+COVID-19 Dual Test (K243561) received a 510(k) decision of Substantially Equivalent on June 17, 2025, 211 days after the submission was received.

What is the product code of K243561?

The FDA product code is SCA – Multi-Analyte Respiratory Virus Antigen Detection Test, a Class II (moderate risk) device regulated under 21 CFR 866.3987.